BioNTech SE (BNTX) Retained Earnings (2018 - 2025)
BioNTech SE (BNTX) posted Retained Earnings of $20.9 billion for Q4 2025, down 2.09% on a QoQ basis from $21.4 billion in Q3 2025, and up 2.45% year-over-year from $20.4 billion in Q4 2024.
BioNTech SE (BNTX) has 8 years of Retained Earnings data on file, last reported at $20.9 billion in Q4 2025.
- In Q4 2025, Retained Earnings rose 2.45% year-over-year to $20.9 billion; the TTM figure through Dec 2025 stood at $20.9 billion (up 2.45% YoY), while the FY2025 annual figure was $20.3 billion, down 0.56% from the prior year.
- Retained Earnings eased to $20.9 billion in Q4 2025, from $21.4 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $21.4 billion in Q3 2025 and bottomed at $54.4 million in Q1 2021.
- A 5-year average of $18.2 billion and a median of $20.5 billion in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 27920.04% — and 2025, when it decreased 6.99%.
- Year by year, Retained Earnings stood at $11.3 billion in 2021, then surged by 69.95% to $19.2 billion in 2022, then grew by 10.67% to $21.3 billion in 2023, then dropped by 4.03% to $20.4 billion in 2024, then grew by 2.45% to $20.9 billion in 2025.
- The last three Retained Earnings figures came in at $20.9 billion (Q4 2025), $21.4 billion (Q3 2025), and $20.7 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 20.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.91 Bn |
| Sep 30, 2025 | 21.36 Bn |
| Jun 30, 2025 | 20.71 Bn |
| Mar 31, 2025 | 19.65 Bn |
| Dec 31, 2024 | 20.41 Bn |
| Sep 30, 2024 | 20.69 Bn |
| Jun 30, 2024 | 20.07 Bn |
| Mar 31, 2024 | 21.13 Bn |
| Dec 31, 2023 | 21.26 Bn |
| Sep 30, 2023 | 21.02 Bn |
| Jun 30, 2023 | 20.85 Bn |
| Mar 31, 2023 | 20.75 Bn |
| Dec 31, 2022 | 19.21 Bn |
| Sep 30, 2022 | 16.69 Bn |
| Jun 30, 2022 | 15.76 Bn |
| Mar 31, 2022 | 15.24 Bn |
| Dec 31, 2021 | 11.31 Bn |
| Mar 31, 2021 | 54.40 Mn |
| Dec 31, 2020 | 488.36 Mn |
| Dec 31, 2019 | -470.24 Mn |
| Sep 30, 2019 | -407.93 Mn |
| Dec 31, 2018 | -280.52 Mn |